CD47, a Ligand for the Macrophage Fusion Receptor, Participates in Macrophage Multinucleation
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The macrophage fusion receptor (MFR), also called P84/BIT/SIRPalpha/SHPS-1, is a transmembrane glycoprotein that belongs to the superfamily of immunoglobulins. Previously, we showed that MFR expression is highly induced at the onset of fusion in macrophages, and that MFR appears to play a role in macrophage-macrophage adhesion/fusion leading to multinucleation. The recent finding that IAP/CD47 acts as a ligand for MFR led us to hypothesize that it interacts with CD47 at the onset of cell-cell fusion. CD47 is a transmembrane glycoprotein, which, like MFR, belongs to the superfamily of immunoglobulins. We show that macrophages express the hemopoietic form of CD47, the expression of which is induced at the onset of fusion, but to a lower level than MFR. A glutathione S-transferase CD47 fusion protein engineered to contain the extracellular domain of CD47, binds macrophages, associates with MFR, and prevents multinucleation. CD47 and MFR associate via their amino-terminal immunoglobulin variable domain. Of the nine monoclonal antibodies raised against the extracellular domain of CD47, three block fusion, as well as MFR-CD47 interaction, whereas the others have no effect. Together, these data suggest that CD47 is involved in macrophage multinucleation by virtue of interacting with MFR during adhesion/fusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CD44 and CD47 are highly induced in macrophages at the onset of fusion and promote fusion and multinucleation, respectively.[66, 67]”
From Foreign body reaction to biomaterials (2008) · cites this paper as [67]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
SNAREpins: Minimal Machinery for Membrane Fusion
Weber, T., Zemelman, B. V., McNew, J. A., Westermann, B., Gmachl, M., Parlati, F., Söllner, T. H., & Rothman, J. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81404-x · Cited by 2,475
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Ribonucleic acid isolated by cesium chloride centrifugation
Glisin, V., Crkvenjakov, R., & Byus, C. (1974) · Biochemistry · doi:10.1021/bi00709a025 · Cited by 2,156
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Rat Insulin Genes: Construction of Plasmids Containing the Coding Sequences
Ullrich, A., Shine, J., Chirgwin, J., Pictet, R., Tischer, E., Rutter, W. J., & Goodman, H. M. (1977) · Science · doi:10.1126/science.325648 · Cited by 1,238
Requirement of CD9 on the Egg Plasma Membrane for Fertilization
Miyado, K., Yamada, G., Yamada, S., Hasuwa, H., Nakamura, Y., Ryu, F., Suzuki, K., Kosai, K., Inoue, K., Ogura, A., et al. (2000) · Science · doi:10.1126/science.287.5451.321 · Cited by 686
A potential fusion peptide and an integrin ligand domain in a protein active in sperm–egg fusion
Blobel, C. P., Wolfsberg, T. G., Turck, C. W., Myles, D. G., Primakoff, P., & White, J. M. (1992) · Nature · doi:10.1038/356248a0 · Cited by 672
A family of proteins that inhibit signalling through tyrosine kinase receptors
Kharitonenkov, A., Chen, Z., Sures, I., Wang, H., Schilling, J., & Ullrich, A. (1997) · Nature · doi:10.1038/386181a0 · Cited by 662
Severely Reduced Female Fertility in CD9-Deficient Mice
Le Naour, F., Rubinstein, E., Jasmin, C., Prenant, M., & Boucheix, C. (2000) · Science · doi:10.1126/science.287.5451.319 · Cited by 646
Research works printed but not linked: 1
- Vignery, A. (1989) Am. J. Pathol. 135, 565-570
Cited by
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138
“[66,67] Dendritic cellspecific transmembrane protein (DC-STAMP) is necessary for fusion in the formation of FBGCs.”
BackgroundWillingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
Franz, S., Rammelt, S., Scharnweber, D., & Simon, J. C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.078 · Cited by 1,391
Phagocytosis checkpoints as new targets for cancer immunotherapy
Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y.-X., & Weissman, I. L. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0183-z · Cited by 911
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050645 · Cited by 890
Integrin-associated protein (CD47) and its ligands
Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 878
Mechanisms of membrane fusion: disparate players and common principles
Martens, S., & McMahon, H. T. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2417 · Cited by 710
The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer
Matlung, H. L., Szilagyi, K., Barclay, N. A., & van den Berg, T. K. (2017) · Immunological Reviews · doi:10.1111/imr.12527 · Cited by 557
The pathology of the foreign body reaction against biomaterials
Klopfleisch, R., & Jung, F. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35958 · Cited by 524
Functions and molecular mechanisms of the CD47–SIRPα signalling pathway
Matozaki, T., Murata, Y., Okazawa, H., & Ohnishi, H. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.12.001 · Cited by 475
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
Veillette, A., & Chen, J. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.12.005 · Cited by 476
CD200 and membrane protein interactions in the control of myeloid cells
Barclay, A. N., Wright, G. J., Brooke, G., & Brown, M. H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02223-8 · Cited by 416
Wiring through tunneling nanotubes--from electrical signals to organelle transfer
Abounit, S., & Zurzolo, C. (2012) · Journal of Cell Science · doi:10.1242/jcs.083279 · Cited by 386
“M-Sec was initially described as tumor necrosis factor-a induced protein 2 (or B94) (Sarma et al., 1992) and subsequently shown to share homology with Sec6 (Hase et al., 2005), a component of the exocyst complex (Hsu et al., 2004).”
BackgroundRANKL-induced DC-STAMP Is Essential for Osteoclastogenesis
Kukita, T., Wada, N., Kukita, A., Kakimoto, T., Sandra, F., Toh, K., Nagata, K., Iijima, T., Horiuchi, M., Matsusaki, H., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040518 · Cited by 358
Targeting CD47 for cancer immunotherapy
Jiang, Z., Sun, H., Yu, J., Tian, W., & Song, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01197-w · Cited by 346
“The N-terminal IgV domain of SIRPα binds to the extracellular Ig domain of CD47 [23, 24].”
BackgroundFusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis
Pawelek, J. M., & Chakraborty, A. K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2371 · Cited by 325
Emerging phagocytosis checkpoints in cancer immunotherapy
Liu, Y., Wang, Y., Yang, Y., Weng, L., Wu, Q., Zhang, J., Zhao, P., Fang, L., Shi, Y., & Wang, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01365-z · Cited by 275
Chen, E. H., Grote, E., Mohler, W., & Vignery, A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.033 · Cited by 263
Self-citationQie, Y., Yuan, H., von Roemeling, C. A., Chen, Y., Liu, X., Shih, K. D., Knight, J. A., Tun, H. W., Wharen, R. E., Jiang, W., et al. (2016) · Scientific Reports · doi:10.1038/srep26269 · Cited by 260
“Mouse recombinant CD47 protein was purchased from R&D systems (Minneapolis, MN), mouse anti-CD47 monoclonal antibodies were purchased from Affymetrix (clone MIAP 301) and generated using hybridoma established previously (clone MIAP 410) 52 .”
Osteoclasts and giant cells: macrophage–macrophage fusion mechanism
Vignery, A. (2000) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2000.00164.x · Cited by 254
“We have also obtained preliminary data indicating that CD47, a ligand for P84/SIRPa/MFR, is expressed by fusing macrophages (Han et al. 2000).”
BackgroundOldenborg, P.-A. (2013) · ISRN Hematology · doi:10.1155/2013/614619 · Cited by 235
“Thefinding thatCD47, by binding to SIRPα, could regulate rat alveolar macrophage fusion and formation of multinucleated giant cells in vitro [184] suggested a function also in regulating formation of bone-resorbing osteoclasts and regulation of bone homeostasis.”
BackgroundVignery, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051123 · Cited by 232
Self-citationKyriakides, T. R., Foster, M. J., Keeney, G. E., Tsai, A., Giachelli, C. M., Clark-Lewis, I., Rollins, B. J., & Bornstein, P. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63265-8 · Cited by 226
“that CD47/integrin-associated protein is a ligand for SHPS-1, and that their interaction is critical for fusion in vitro.(36,37) Furthermore, the participation of CD44, an integral membrane glycoprotein, in alveolar macrophage fusion has been documented.”
BackgroundSignal Regulatory Protein (SIRPα), a Cellular Ligand for CD47, Regulates Neutrophil Transmigration
Liu, Y., Bühring, H.-J., Zen, K., Burst, S. L., Schnell, F. J., Williams, I. R., & Parkos, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109720200 · Cited by 217
Signal Regulatory Proteins in the Immune System
van Beek, E. M., Cochrane, F., Barclay, A. N., & van den Berg, T. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7781 · Cited by 204
“Apart from the above, reported evidence suggests that SIRP -CD47 interactions play a role in macrophage fusion to form multinucleated cells in vitro (33, 34).”
BackgroundFlorman, H. M., & Fissore, R. A. (2015) · Knobil and Neill's Physiology of Reproduction · doi:10.1016/b978-0-12-397175-3.00004-1 · Cited by 199
Macrophage and dendritic cell phenotypic diversity in the context of biomaterials
Kou, P. M., & Babensee, J. E. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32971 · Cited by 190
CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
Sick, E., Jeanne, A., Schneider, C., Dedieu, S., Takeda, K., & Martiny, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02099.x · Cited by 176
“The interaction of CD47 with SIRPa contributes to fusion of rat alveolar macrophages and the generation of multinucleated cells (Han et al., 2000) that can differentiate into osteoclasts in bone.”
BackgroundMiyamoto, H., Suzuki, T., Miyauchi, Y., Iwasaki, R., Kobayashi, T., Sato, Y., Miyamoto, K., Hoshi, H., Hashimoto, K., Yoshida, S., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1575 · Cited by 171
The CD47-SIRP signalling system: its physiological roles and therapeutic application
Murata, Y., Kotani, T., Ohnishi, H., & Matozaki, T. (2014) · Journal of Biochemistry · doi:10.1093/jb/mvu017 · Cited by 169
Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions
Schneider, J. G., Amend, S. R., & Weilbaecher, K. N. (2011) · Bone · doi:10.1016/j.bone.2010.09.016 · Cited by 169
“myeloid cells and that likely participates in early fusion events [102].”
Osteoclast Multinucleation: Review of Current Literature
Kodama, J., & Kaito, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165685 · Cited by 167
“The transmembrane glycoprotein CD47 has been identified as its ligand, and their interaction is essential for the onset of osteoclast fusion [94].”
BackgroundMarshall, A. S. J., Willment, J. A., Lin, H.-H., Williams, D. L., Gordon, S., & Brown, G. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313127200 · Cited by 162
The molecular basis of macrophage fusion
Helming, L., & Gordon, S. (2008) · Immunobiology · doi:10.1016/j.imbio.2007.09.012 · Cited by 157
Helming, L., & Gordon, S. (2007) · European Journal of Immunology · doi:10.1002/eji.200636788 · Cited by 146
Yamao, T., Noguchi, T., Takeuchi, O., Nishiyama, U., Morita, H., Hagiwara, T., Akahori, H., Kato, T., Inagaki, K., Okazawa, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203287200 · Cited by 139
Leukocyte–epithelial interactions
Zen, K., & Parkos, C. A. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00103-0 · Cited by 135
“Indeed, such interactions have been proposed to play a role in a CD47–SIRPa-mediated multinucleation response in macrophages [59].”
BackgroundCastellano, P., Prevedel, L., & Eugenín, E. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12758-w · Cited by 152
Brooks, P. J., Glogauer, M., & McCulloch, C. A. (2019) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.02.006 · Cited by 126
Cell fusion during development
Oren‐Suissa, M., & Podbilewicz, B. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.09.004 · Cited by 128
Macrophage fusion: are somatic and cancer cells possible partners?
Vignery, A. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.02.008 · Cited by 124
Loss of ABCG1 Results in Chronic Pulmonary Inflammation
Baldán, A., Gomes, A. V., Ping, P., & Edwards, P. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3560 · Cited by 122
Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells
Yagi, M., Miyamoto, T. K., Toyama, Y., & Suda, T. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0697-9 · Cited by 135
Osteoclast fusion and regulation by RANKL-dependent and independent factors
Xing, L., Xiu, Y., & Boyce, B. F. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i12.212 · Cited by 131
Ahmadzadeh, K., Vanoppen, M., Rosé, C. D., Matthys, P., & Wouters, C. H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.873226 · Cited by 131
CMRF-35-Like Molecule-1, a Novel Mouse Myeloid Receptor, Can Inhibit Osteoclast Formation
Chung, D.-H., Humphrey, M. B., Nakamura, M. C., Ginzinger, D. G., Seaman, W. E., & Daws, M. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6541 · Cited by 118
“Furthermore, a fusion protein containing the extracellular IgV domain of SIRP is able to block monocyte fusion (36, 38).”
BackgroundGene Expression Changes in the Course of Neural Progenitor Cell Differentiation
Gurok, U., Steinhoff, C., Lipkowitz, B., Ropers, H.-H., Scharff, C., & Nuber, U. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0809-04.2004 · Cited by 112
Ishii, M., Iwai, K., Koike, M., Ohshima, S., Kudo-Tanaka, E., Ishii, T., Mima, T., Katada, Y., Miyatake, K., Uchiyama, Y., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060308 · Cited by 112
The intracellular domain of CD44 promotes the fusion of macrophages
Cui, W. (2006) · Blood · doi:10.1182/blood-2005-05-1902 · Cited by 110
SHPS‐1, a multifunctional transmembrane glycoprotein
Oshima, K., Ruhul Amin, A. R. M., Suzuki, A., Hamaguchi, M., & Matsuda, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02703-5 · Cited by 104
Dou, C., Zhang, C., Kang, F., Yang, X., Jiang, H., Bai, Y., Xiang, J., Xu, J., & Dong, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.08.002 · Cited by 108
Original insights on thrombospondin-1-related antireceptor strategies in cancer
Jeanne, A., Schneider, C., Martiny, L., & Dedieu, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00252 · Cited by 108
“Of note, one of the CD47-blocking antibody that reduced tumor growth (clone miap410; Willingham et al., 2012b) raised doubts as to its ability to block CD47:SIRPα interaction (Han et al., 2000; Willingham et al., 2012b).”
BackgroundThe origins and formation of bone-resorbing osteoclasts
Elson, A., Anuj, A., Barnea-Zohar, M., & Reuven, N. (2022) · Bone · doi:10.1016/j.bone.2022.116538 · Cited by 95
Regulation of Integrin Function by CD47 Ligands
Barazi, H. O., Li, Z., Cashel, J. A., Krutzsch, H. C., Annis, D. S., Mosher, D. F., & Roberts, D. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206849200 · Cited by 90
Lundberg, P., Koskinen, C., Baldock, P. A. J., Löthgren, H., Stenberg, Å., Lerner, U. H., & Oldenborg, P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.057 · Cited by 103
Marquardt, J. U., Seo, D., Gómez-Quiroz, L. E., Uchida, K., Gillen, M. C., Kitade, M., Kaposi-Novak, P., Conner, E. A., Factor, V. M., & Thorgeirsson, S. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.012 · Cited by 88
“Multinucleated cells were positive for F4/80, a marker of infiltrating macrophages, and expressed CD47, known to contribute to macrophage fusion thought to increase the capacity to remove or sequester necrotic material (Figure 3, B and C) [31].”
BackgroundCD47: the next checkpoint target for cancer immunotherapy
Feng, R., Hai, Z., Xu, J., & Shen, C. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103014 · Cited by 88
Role of the CD47–SHPS‐1 system in regulation of cell migration
Motegi, S., Okazawa, H., Ohnishi, H., Sato, R., Kaneko, Y., Kobayashi, H., Tomizawa, K., Ito, T., Honma, N., Bühring, H., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg278 · Cited by 87
Olsson, M., & Oldenborg, P.-A. (2008) · Blood · doi:10.1182/blood-2008-03-143008 · Cited by 86
Deciphering the role of CD47 in cancer immunotherapy
Liu, Y., Weng, L., Wang, Y., Zhang, J., Wu, Q., Zhao, P., Shi, Y., Wang, P., & Fang, L. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.10.009 · Cited by 91
“Low-dose or low-erythrocyte agglutination reaction s in vitro and long-term treatment have been attempted [290,303], however, anemia and other adverse reactions still occur in actual clinical trials, therefore, erythrocyte agglutination is not the main cause of anemia [304].”
BackgroundWitwicka, H., Hwang, S.-Y., Reyes-Gutierrez, P., Jia, H., Odgren, P. E., Donahue, L. R., Birnbaum, M. J., & Odgren, P. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128275 · Cited by 80
“CD47 and its interacting receptor, SIRP α , have been shown to be important in macrophage/osteoclast fusion [26 – 28], but they are very widely expressed.”
BackgroundFrazão, J. B., Errante, P. R., & Condino‐Neto, A. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0243-0 · Cited by 89
Kukreja, A., Radfar, S., Sun, B., Insogna, K. L., & Dhodapkar, M. V. (2009) · Blood · doi:10.1182/blood-2009-03-211920 · Cited by 83
“CD1 female mice were infused with human (1-34)PTH at 15 pmoles/hr for 5 days via Alzett minipump implanted subcutaneously in the interscapular region.”
MethodRebres, R. A., Vaz, L. E., Green, J. M., & Brown, E. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106107200 · Cited by 76
The development of small-molecule inhibitors targeting CD47
Yu, W., Ye, Z.-H., Chen, X., Shi, J.-J., & Lu, J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.003 · Cited by 79
Cameron, C., Barrett, J. W., Mann, M. J., Lucas, A., & McFadden, G. (2005) · Virology · doi:10.1016/j.virol.2005.03.037 · Cited by 74
“This is critical in that it is through the N-terminal immunoglobulin domain that CD47 interacts with the inhibitory SIRPa family members (Brooke et al., 2004; Han et al., 2000; Liu et al., 2004).”
BackgroundMøller, A. M. J., Delaissé, J., & Søe, K. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25633 · Cited by 74
“However, also other factors such as CD47 (Han et al., 2000; Lundberg et al., 2007; Maile et al., 2011; Koskinen et al., 2013; HoboltPedersen et al., 2014), syncytin-1 (Soe et al., 2011), OC-STAMP (osteoclast stimulatory transmembrane protein) (Miyamoto et al., 2012; Witwicka et al., 2015), dynamin…”
Horrigan, S. K., & Reproducibility Project: Cancer Biology (2017) · eLife · doi:10.7554/elife.18173 · Cited by 72
“While the original study included two clones of anti-CD47 (MIAP410 [Han et al., 2000] and MIAP301 [Lindberg et al., 1993]), this replication attempt was restricted to only one clone, MIAP410, which had the larger reported effect size of the two clones in the original experiment (Willingham et al.,…”
CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts
Cui, W., Cuartas, E., Ke, J. Z., Zhang, Q., Einarsson, H. B., Sedgwick, J. D., Li, J., & Vignery, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702811104 · Cited by 81
Role of NADPH Oxidase in Formation and Function of Multinucleated Giant Cells
Quinn, M. T., & Schepetkin, I. A. (2009) · Journal of Innate Immunity · doi:10.1159/000228158 · Cited by 79
Osteoclast cell fusion: mechanisms and molecules
Ishii, M., & Saeki, Y. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0051-2 · Cited by 70
Trebec‐Reynolds, D. P., Chandra, D., Gramoun, A., Li, K., Heersche, J. N. M., & Manolson, M. F. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21171 · Cited by 77
“SIRPa1 (AKA p84/ BIT/SHPS-1) has been implicated in macrophage fusion through interaction with CD47 [Han et al., 2000; Vignery, 2000; Seiffert et al., 2001; Liu et al., 2002; Oshima et al., 2002].”
BackgroundMechanosensing by TRPV4 mediates stiffness-induced foreign body response and giant cell formation
Goswami, R., Arya, R. K., Sharma, S., Dutta, B., Stamov, D. R., Zhu, X., & Rahaman, S. O. (2021) · Science Signaling · doi:10.1126/scisignal.abd4077 · Cited by 71
Specific recognition of virus‐infected cells by paired NK receptors
Arase, H., & Lanier, L. L. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.422 · Cited by 79
Don't eat me/eat me signals as a novel strategy in cancer immunotherapy
Khalaji, A., Yancheshmeh, F. B., Farham, F., Khorram, A., Sheshbolouki, S., Zokaei, M., Vatankhah, F., & Soleymani-Goloujeh, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20507 · Cited by 72
“CD47 features an extended N-terminal extracellular domain and 5 transmembrane helices, interacting with SIRP α [79,80] to serve as a "Don ’ t eat me" signal to macrophages.”
Levaot, N., Ottolenghi, A., Mann, M., Ram, G. G., Kam, Z., & Geiger, B. (2015) · Bone · doi:10.1016/j.bone.2015.05.021 · Cited by 71
“Further support for heterogeneity in cultures of osteoclast progenitors comes from recent findings that human blood monocyte cells express different levels and subcellular distributions of fusionregulating genes such as CD47, DC-STAMP, and Syncytin-1 [35].”
BackgroundDistinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells
Parthasarathy, V., Martin, F., Higginbottom, A., Murray, H., Moseley, G. W., Read, R. C., Mal, G., Hulme, R., Monk, P. N., & Partridge, L. J. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02945.x · Cited by 80
Osteoclast Fusion is Based on Heterogeneity Between Fusion Partners
Hobolt-Pedersen, A.-S., Delaissé, J.-M., & Søe, K. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9864-5 · Cited by 61
Resolvin E1 regulates osteoclast fusion via DC‐STAMP and NFATc1
Zhu, M., Dyke, T. E. V., & Gyurko, R. (2013) · The FASEB Journal · doi:10.1096/fj.12-220228 · Cited by 69
Dahl, K. N., Westhoff, C. M., & Discher, D. E. (2003) · Blood · doi:10.1182/blood-2002-04-1187 · Cited by 60
Dual Regulation of SIRPα Phosphorylation by Integrins and CD47
Johansen, M. L., & Brown, E. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701565200 · Cited by 59
Molecular and Cellular Mechanisms of Mammalian Cell Fusion
Zhou, X., & Platt, J. L. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0763-4_4 · Cited by 65
Liu, Y., O’Connor, M. B., Mandell, K. J., Zen, K., Ullrich, A., Bühring, H.-J., & Parkos, C. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2578 · Cited by 58
“multinucleation (20), self-recognition of RBC and sickle cell clear-”
BackgroundGarrigues, G. E., Cho, D. R., Rubash, H. E., Goldring, S. R., Herndon, J. H., & Shanbhag, A. S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.034 · Cited by 66
The elementary fusion modalities of osteoclasts
Søe, K., Hobolt-Pedersen, A.-S., & Delaissé, J. (2014) · Bone · doi:10.1016/j.bone.2014.12.010 · Cited by 62
“role in OC fusion [13–15,34,35], that could be involved in the selection of fusion partners according to differences in mobility and differentiation status.”
BackgroundSøe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207717 · Cited by 55
“CD47 is, just as DC-STAMP, primarily expressed in pre-osteoclasts and expression decreases as the osteoclast gains nuclei [40,41].”
BackgroundCD47: A New Target in Cardiovascular Therapy
Isenberg, J. S., Roberts, D. D., & Frazier, W. A. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.158154 · Cited by 59
Liu, Y., Soto, I., Tong, Q., Chin, A., Bühring, H.-J., Wu, T., Zen, K., & Parkos, C. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506419200 · Cited by 54
The CD47-SIRPα axis is a promising target for cancer immunotherapies
Hao, Y., Zhou, X., Li, Y., Li, B., & Lei, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110255 · Cited by 61
Yu, M., Qi, X., Moreno, J. L., Färber, D. L., & Keegan, A. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002628 · Cited by 58
Lemaire, I. B., Falzoni, S., Zhang, B., Pellegatti, P., & Virgilio, F. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002780 · Cited by 61
“It is thought that MA–MA fusion is mediated by receptor–ligand interaction, and several cell membrane molecules such as b-integrins receptors (4), CD44 (15), CD47 (16), CD98 (17), the transmembrane glycoprotein ADAM 9 (18), and the dendritic cell-specific transmembrane protein (DC-STAMP) (12) have been identified as m…”
BackgroundGorczynski, R. M., Chen, Z., Clark, D. A., Yu, K., Lee, L., Nachman, J., Wong, S. Y. C., & Marsden, P. A. (2004) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2004.00192.x · Cited by 61
“Both CD47 and SIRPa can be expressed by macrophages, thus also potentially allowing for homotypic intercellular signaling.(40,41) For instance, there is evidence that CD47/ SIRPa engagement on dendritic cells alters cytokine production and modulates T-cell activation.”
BackgroundDual Effect of Cyanidin on RANKL‐Induced Differentiation and Fusion of Osteoclasts
Dou, C., Li, J., Kang, F., Cao, Z., Yang, X., Jiang, H., Yang, B., Xiang, J., Xu, J., & Dong, S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24916 · Cited by 57
Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells
Dahl, K. N., Parthasarathy, R., Westhoff, C. M., Layton, D. M., & Discher, D. E. (2003) · Blood · doi:10.1182/blood-2003-04-1331 · Cited by 54
Virus-driven evolution of natural killer cell receptors
Arase, H., & Lanier, L. L. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00033-3 · Cited by 61
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
Zhou, Z., Chen, M.-J. M., Luo, Y., Mojumdar, K., Peng, X., Chen, H., Kumar, S. V., Akbani, R., Lu, Y., & Liang, H. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.10.012 · Cited by 53
“The shRNA showing themost robust knockdown efficiency was selected for e controls, respectively. ures of different ratios of B16F10 and CD8+ T cells (Pmel-1) without (E) and with ifferentiation antigens in B16F10 cells with SIRPA KD, OE, or control. sig., log2 justed p > 0.05 by DESeq2. ith CD8+ T cells (Pmel-1) pretr…”
MethodInfluentialIwai, K., Ishii, M., Ohshima, S., Miyatake, K., & Saeki, Y. (2007) · Allergology International · doi:10.2332/allergolint.o-07-488 · Cited by 50
Multinucleated Giant Cells in Experimental Intracerebral Hemorrhage
Wei, J., Wang, M., Jing, C., Keep, R. F., Hua, Y., & Xi, G. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00790-4 · Cited by 48
Tulasne, D., Judd, B. A., Johansen, M., Asazuma, N., Best, D., Brown, E. J., Kahn, M. L., Koretzky, G. A., & Watson, S. P. (2001) · Blood · doi:10.1182/blood.v98.12.3346 · Cited by 55
Koduru, S. V., Sun, B.-H., Walker, J. M., Zhu, M., Simpson, C. A., Dhodapkar, M. V., & Insogna, K. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000633 · Cited by 50
“CD47 has also been implicated in cell fusion, an essential step in the formation of OCLs from macrophages (11, 12).”
Background
Metadata
- Authors
- Han, X., Sterling, H., Chen, Y., Saginario, C., Brown, E. J., Frazier, W. A., Lindberg, F. P., & Vignery, A.
- Affiliations
- Yale University (US)
- Washington University in St. Louis (US)
- University of California, San Francisco (US)
- Corresponding author
- Vignery, Agnès
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 48
- Pages
- 37984-37992
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2028407058
- Cited by
- 245
- References
- 36
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 10 · 2023: 8 · 2022: 10 · 2021: 6 · 2020: 11 · 2019: 6 · 2018: 5 · 2017: 8 · 2016: 8 · 2015: 10 · 2014: 11 · 2013: 10 · 2012: 14
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7244 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM057573, GM57573-01)
- National Institute of Dental and Craniofacial Research (DE12110, R01DE012110)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- CD47, macrophage fusion, multinucleation, cell-cell adhesion, immunoglobulin superfamily, SIRPα, monoclonal antibodies, GST fusion protein, immunoglobulin variable domains
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Differentiation, Base Sequence, Carrier Proteins, Cell Fusion, Cell Nucleus, Ligands, Macrophages, Membrane Glycoproteins, Receptors, Immunologic, Antigens, CD, DNA Primers, Neural Cell Adhesion Molecules, Neural Cell Adhesion Molecule L1, Rats, CD47 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.